Seelos therapeutics to participate in 43rd annual cowen health care conference

New york , feb. 15, 2023 /prnewswire/ -- seelos therapeutics, inc. (nasdaq: seel), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in the 43rd annual cowen health care conference, to be held in boston, massachusetts on march 6-8th, 2023.  raj mehra ph.d.
SEEL Ratings Summary
SEEL Quant Ranking